Free News Archives
Latest Issue of OR Manager
February 2025

Joint Commission issues new Sentinel Event Alert on violence against healthcare workers

Editor's Note The Joint Commission on April 17 announced that it had issued a new Sentinel Event Alert 59: Physical and verbal violence against healthcare workers. The Joint Commission issued the alert during Workplace Violence Awareness Month to help healthcare workers in hospitals and other healthcare settings recognize violence from…

Read More

By: Judy Mathias
April 18, 2018
Share

FDA approves firmware update for Abbott ICDs, CRT-Ds

Editor's Note The Food and Drug Administration (FDA) on April 17 announced that it had approved a firmware update that is now available for certain Abbott (formerly St Jude Medical) implantable cardiac devices (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). The update is a corrective action (recall) to reduce the…

Read More

By: Judy Mathias
April 18, 2018
Share

Daily preop opioid use linked to worse outcomes after scoliosis surgery

Editor's Note Daily narcotic use before adult spinal deformity (ASD) surgery was associated with poorer outcomes 2 years postoperatively, this study finds. In this multicenter analysis of 575 patients, 425 had complete 2-year follow-up. A total of 44% reported daily preoperative narcotic use. Compared with non-daily users, daily narcotic users…

Read More

By: Judy Mathias
April 16, 2018
Share

FDA alert: Coastal Meds recalls all sterile products

Editor's Note The Food and Drug Administration (FDA) on April 13 announced the recall by Coastal Meds (Biloxi, Mississippi) of all nonexpired products marketed as sterile because of visible particles in some of the drug vials for injection and poor sterile production practices. The FDA on April 5 requested the…

Read More

By: Judy Mathias
April 16, 2018
Share

Effect perioperative ß-blockade with increasing patient age

Editor's Note No difference was found in the effect of perioperative ß-blockade (metoprolol continuous release 200 mg for 30 days) versus placebo on postoperative outcomes between older and younger patients in this study (POISE [perioperative ischemia evaluation] trial). In this analysis of 8,351 patients from 190 centers in 23 countries,…

Read More

By: Judy Mathias
April 16, 2018
Share

FDA: Premier Pharmacy Labs recalls certain sterile injectable products

Editor's Note The Food and Drug Administration (FDA) on April 12 announced the recall by Premier Pharmacy Labs (Weeki Wachee, Florida) of certain lots of sterile injectable products because of a potential lack of sterility assurance. The products include morphine sulfate (2 mg/mL and 3 mg/mL), hydromorphone HCL 1 mg/mL,…

Read More

By: Judy Mathias
April 16, 2018
Share

Effectiveness of video vs live observation in improving OR teamwork

Editor's Note Video observation was not be as effective as evaluating live performance in promoting OR teamwork in this study. A total of 1,410 briefs were analyzed−325 live observations and 1,085 videos−and 1,398 debriefs were evaluated−166 live and 1,232 video. For briefs, there was greater compliance with live observation than…

Read More

By: Judy Mathias
April 13, 2018
Share

Joint Commission releases 2017 top 5 most challenging requirements

Editor's Note The Joint Commission on April 11 released the top 5 requirements identified most frequently as “not compliant” during surveys and reviews that took place from January 1 to December 31, 2017. New to the table is data on Perinatal Care Certification. The top 5 for Hospital Accreditation are:…

Read More

By: Judy Mathias
April 13, 2018
Share

FDA: Recall of Acrodose Plus and PL systems by Haemonetics

Editor's Note The Food and Drug Administration (FDA) on April 13 announced the recall by Haemonetics (Braintree, Massachusetts) of certain lots of its Acrodose Plus and PL Systems because the company has received reports of low pH readings for platelets stored in CLX HP bags. In some instances the drop…

Read More

By: Judy Mathias
April 13, 2018
Share

Hysterectomy complication rates after FDA warning against power morcellation

Editor's Note In this study, 30-day complications rates increased after the Food and Drug Administration (FDA) warned against the use of power morcellation in women undergoing hysterectomy for benign gynecologic indications. In a cohort of 75,487 women who had hysterectomies, statistically and clinically significant increases in major (1.9% to 2.4%)…

Read More

By: Judy Mathias
April 11, 2018
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat